By Topic

Prokaryotic expression and analysis on the ag85b-mpb64 fusion gene of Mycobacterium bovis

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$33 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

11 Author(s)
Xiuyun Jiang ; College of Life Sciences, Jilin Agricultural University, Changchun, China ; Daming Gao ; Chunfang Wang ; Lei Liu
more authors

For raising the antigenicity of Mycobacterium bovis single antigen, fusion protein of two genes was acquired. The DNA fragments of ag85b and mpb64 were fused by splicing by overlapping extension (SOE) polymerase chain reaction(PCR), and the fusion gene ag85b-mpb64 were cloned into pMD-18-T vector, then we got the recombinant plasmid pMD-85b-64. pMD-85b-64 and pET28a(+) were digested by BamH I and EcoR I double enzymes. The purified pMD-85b-64 fusion gene was subcloned into the expression vector pET28a(+), and the prokaryotic expression vector pET-85b-64 was constructed. Plasmid containing pET-85b-64 was transformed into competence Escherichia coli BL21 (DE3). The bacterium was induced by isopropyl-β-D-thiogalactopyranoside(IPTG) and its lysates were loaded directly onto sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE), approximately 58 ku exogenous protein was observed on the SDS-PAGE. The protein was analyzed by using Western blotting, the results indicated that the protein was of antigenic activity of Mycobacterium bovis. These results could serve as a basis for further studies on the usefulness of the fusion gene and its expression product in the development of subunit vaccine and DNA vaccine against bovine tuberculosis.

Published in:

2011 4th International Conference on Biomedical Engineering and Informatics (BMEI)  (Volume:4 )

Date of Conference:

15-17 Oct. 2011